Korro Bio (KRRO) Return on Invested Capital (2022 - 2023)
Korro Bio (KRRO) posted Return on Invested Capital of 0.05% for Q4 2023, down 152.63% on a QoQ basis from 0.02% in Q3 2023, and down 2.0% year-over-year from 0.05% in Q4 2022.
Korro Bio (KRRO) Return on Invested Capital (2022 - 2023) Analysis & Trends
Korro Bio's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.05% for Q4 2023.
- Quarterly Return on Invested Capital fell 2.0% year-over-year to 0.05% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.05% (down 2.0% YoY) and the FY2022 annual result came in at 0.11%, changed N/A from the prior year.
- Return on Invested Capital was 0.05% for Q4 2023 at Korro Bio, down from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.02% in Q2 2023 and bottomed at 0.35% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -0.13% |
| Mar 31, 2022 | -0.35% |